Suchergebnisse - "O3J8G9O825"

PubPharm (5.515)

51

Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Carlson, J. | Foos, V. | Kasle, A. | +7

52

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

53

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19 : a retrospective cohort study

enthalten in: Scientific reports | 2024

von Chen, M. | Jiang, D. | Rang, J. | +2

54

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

55

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2024

von Brosh-Nissimov, T. | Ma'aravi, N. | Leshin-Carmel, D. | +5

56

Advanced 3D Electrospinning "Xspin" System : Fabrication of Bifiber Floating Oral Pharmaceutical Scaffolds for Controlled Drug Delivery

enthalten in: Molecular pharmaceutics | 2024

von Darwesh, A. | Zhang, Y. | Aghda, N. | +2

57

Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

enthalten in: Infection | 2024

von Fernández-de-Las-Peñas, C. | Torres-Macho, J. | Catahay, J. | +8

ErratumIn: Infection. 2024 Mar 7;:. - PMID 38451416

58

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

59

Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2024

von Zheng, L. | Zhang, W. | Olkkola, K. | +6

60

Nirmatrelvir/ritonavir and pharmacovigilance data

enthalten in: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease | 2024

von Lassan, S. | Gocova, M. | Solovic, I. | +3